BlogZone Get the app
Business

Novo CEO Doustdar On What’s New For Ozempic, Wegovy, GLP-1s, Obesity

Forbes Business 12 Nov 2026 1 views

Novo president and chief executive officer Mike Doustdar talked about Ozempic, Wegovy, new GLP-1 medications, weight loss and obesity and the company's new rebrand

BlogZone shows headlines and summaries from public news feeds. The full story is published by Forbes Business.

Read the full story at Forbes Business →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Business

Business

Red Sox Veteran Targets Return After Dominant Stretch

The Boston Red Sox have received an update from a four-year veteran who seems to have transformed his game.

Forbes Business · 43 min ago
Business

Zelenskyy Says SpaceX’s Starshield Restrictions Have Returned—Disrupting Ukraine’s Drone Defenses

Zelenskyy said the renewed restriction on his country’s use of the military version of SpaceX’s Starlink internet service allowed Russian drone strikes to breach Ukraine’s defenses.

Forbes Business · 1 hour ago
Business

Mets Send First Base Message After Free Agent Exit

New York Mets executive David Stearns indicated his plans for the key infield position shortly after a contributor cut ties with the team.

Forbes Business · 1 hour ago